Guangzhou Concord Cancer Center Proton Therapy Center Recognized Among China's Leading Proton Therapy Centers
Official recognition banner — Guangzhou Concord Cancer Center Proton Therapy Center ranked #3 nationwide in Proton China's 2024–2025 Best Proton & Heavy Ion Centers in China ranking.
Recently, Proton China released its 2024–2025 Best Proton & Heavy Ion Centers in China Ranking. Guangzhou Concord Cancer Center Proton Therapy Center was ranked third nationwide, reflecting its growing influence and clinical strength in the field of particle therapy.
The ranking evaluates proton and heavy ion centers across five key dimensions: technology and equipment, medical expertise, clinical capabilities, compliance and quality management, and patient treatment experience. These criteria provide a comprehensive assessment of each center's overall performance and service quality.
- Technology & Equipment: Advanced treatment systems, beam delivery platforms, and supporting infrastructure
- Medical Expertise: Clinical team qualifications, specialist experience, and academic credentials
- Clinical Capabilities: Treatment volume, case complexity, and disease-specific outcomes
- Compliance & Quality Management: Regulatory adherence, safety protocols, and QA standards
- Patient Treatment Experience: Care coordination, service accessibility, and patient satisfaction
As one of China's major operational proton therapy centers, Guangzhou Concord Cancer Center continues to advance precision radiation oncology while strengthening its multidisciplinary clinical services for cancer patients from China and around the world.
The full TOP 10 national ranking list released by Proton China — Guangzhou Concord Cancer Center Proton Therapy Center stands proudly at #3 among all operational proton and heavy ion centers in China.
As of April 2026, the center has treated more than 800 patients and achieved an average daily treatment volume exceeding 100 sessions. The team has developed extensive experience in treating pediatric cancers, brain tumors, head and neck cancers, thoracic malignancies, and other complex tumor types.
Clinical Expertise Highlights:
The team has accumulated extensive experience across a wide spectrum of complex tumor indications:
• Pediatric cancers — specialized protocols for young patients
• Brain tumors — precision sparing of critical neural structures
• Head and neck cancers — preserving swallowing and speech functions
• Thoracic malignancies — minimizing cardiac and pulmonary exposure
• Other complex tumor types — individualized treatment plans
Supported by advanced proton therapy technology, a highly specialized multidisciplinary team, and rigorous quality assurance standards, the hospital strives to maximize treatment precision while minimizing radiation exposure to surrounding healthy tissues and critical organs.
"This recognition highlights the hospital's achievements in clinical excellence and patient-centered care, while also reflecting its contribution to the ongoing development of high-quality proton therapy services in China." — Proton China, 2024–2025 National Ranking Report
A multidisciplinary clinical team carefully positions a patient on the proton therapy bed — reflecting GCCC's commitment to precision, care coordination, and patient-centered treatment delivery.
Looking ahead, Guangzhou Concord Cancer Center will continue to promote clinical innovation, research collaboration, and international academic exchange, with the goal of delivering advanced, safe, and high-quality cancer care to patients worldwide.
Strategic Direction:
Guangzhou Concord Cancer Center is committed to:
• Advancing clinical innovation in precision radiation oncology
• Strengthening research collaboration with leading global institutions
• Expanding international academic exchange and knowledge sharing
• Delivering advanced, safe, and high-quality cancer care worldwide
Source: Proton China (Original Article)
Ranking Period: 2024–2025 Annual Edition
Publisher: Proton China